Bramshill Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bramshill Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Sell	11,000 -1,000	-8%	-$135K	0.13%	28
2026 Q1	$1.53M	Buy	12,000 +3,500	+41%	+$437K	0.13%	30
2025 Q4	$1.04M	Sell	8,500 -4,000	-32%	-$459K	0.06%	60
2025 Q3	$1.25M	Hold	12,500	–	–	0.09%	46
2025 Q2	$1.04M	Buy	12,500 +5,500	+79%	+$439K	0.11%	56
2025 Q1	$568K	Buy	+7,000	New	+$626K	0.06%	115

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Bramshill Investments's XBI Position: Q2 2026 in Review

Bramshill Investments reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 8.3% in Q2 2026, selling an estimated $135K and leaving 11,000 shares worth $1.74M. The position accounts for 0.13% of the portfolio, ranked #28.

Bramshill Investments first reported a position in XBI in Q1 2025 and has held it in 6 quarters since. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Bramshill Investments held 11,000 shares of State Street SPDR S&P Biotech ETF worth $1.74M as of Q2 2026.
Bramshill Investments sold 1,000 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $135K.
State Street SPDR S&P Biotech ETF made up 0.13% of Bramshill Investments's portfolio in Q2 2026, its #28 holding.
Bramshill Investments first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 6 quarters since.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bramshill Investments's 13F filing for Q2 2026, filed 14 Aug 2026.